Analysts Upgrades – AMED, RGS, MYRG

Share



The following stocks have recently had their ratings upgraded by stock analysts.

Amedisys (AMED)

Deutsche Bank has upgraded Amedisys’s rating
from: Hold – to – Buy
Target Price: $39.00

Regis (RGS)

Wedbush has upgraded Regis’s rating
from: Neutral – to – Outperform
Target Price: $22.00

MYR Group (MYRG)

Wedbush has upgraded MYR Group’s rating
from: Neutral – to – Outperform
Target Price: $26.00

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.